Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ProSomnus, Inc. - Common Stock (NQ: OSA ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about ProSomnus, Inc. - Common Stock < Previous 1 2 3 Next > OSA Stock Earnings: ProSomnus Misses EPS, Beats Revenue for Q4 2023 March 27, 2024 OSA stock results show that ProSomnus missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session March 26, 2024 Via Benzinga ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results March 26, 2024 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call March 15, 2024 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire Roth MKM Maintains Buy Rating for ProSomnus: Here's What You Need To Know September 26, 2023 Via Benzinga Earnings Scheduled For March 26, 2024 March 26, 2024 Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million. Via Benzinga Top 4 Health Care Stocks That Are Preparing To Pump This Month February 23, 2024 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea February 22, 2024 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024 February 20, 2024 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA January 30, 2024 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices January 29, 2024 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea January 08, 2024 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session December 19, 2023 Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session December 19, 2023 Via Benzinga Why Is Sleep Devices Focused ProSomnus Stock Soaring Today? December 19, 2023 ProSomnus Inc (NASDAQ: OSA) announced the publication of a study by the Cureus Journal of Medical Science, highlighting the company's precision oral appliance therapy (OAT) devices for Via Benzinga Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices December 19, 2023 Additional clinical research indicates patients using ProSomnus devices have decreased apnea-hypopnea index events per hour, with strong treatment adherence From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Thursday's Intraday Session November 30, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session November 30, 2023 Via Benzinga Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket November 30, 2023 Shares of Salesforce, Inc. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 30, 2023 It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning! Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session November 17, 2023 Via Benzinga ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results November 09, 2023 Record quarterly revenue of $7.1 million represents an increase of 41.5% year-over-year and seventh consecutive quarter of sequential revenue growth From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire ProSomnus Announces Third Quarter 2023 Investor Call and Business Update October 31, 2023 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session October 26, 2023 Gainers Via Benzinga ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference October 03, 2023 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations September 21, 2023 Company will leverage new capital inflow to optimize core business operations, advance strategic growth initiatives, and achieve cash flow breakeven From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire EXCLUSIVE: Sleep Disorder Focused ProSomnus Raises $10M To Fuel Growth, Optimize Operations September 21, 2023 ProSomnus Inc (NASDAQ: OSA) has completed a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital. ProSomnus's Executive Chair, CEO, and... Via Benzinga ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences September 14, 2023 Scientific Abstracts and Presentations Feature New and Additional Data Demonstrating the Efficacy, Effectiveness, and Safety of ProSomnus Precision Devices for the Treatment of Obstructive Sleep Apnea From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea August 23, 2023 From ProSomnus Sleep Technologies, Inc. Via GlobeNewswire EXCLUSIVE: ProSomnus' Device Therapy Better Than Philip's Device(s) For Sleep-Related Breathing Disorder, Study Shows August 23, 2023 ProSomnus Inc (NASDAQ: OSA), a provider of CPAP alternatives for Obstructive Sleep Apnea, announced updated data presented at the ProSleep Conference earlier this month. The updated data indicate the... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
